发展SMA EFFORT:一种新的方法来描述脊髓肌肉缩中感知到的身体疲劳

相关实验视频

Updated: May 27, 2025

07:22

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Published on: February 20, 2020

5.8K

Rafael Rodriguez-Torres^1,2,3, Cara H Kanner^1,3, Emma L Gay⁴

¹Departments of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Journal of neuromuscular diseases

|February 20, 2025

概括

脊椎肌肉缩 (SMA) 患者经历疲劳. 新的SMA EFFORT尺度有效地测量了SMA患者的感知身体疲劳 (PPF),改善了对身体健康的评估.

科学领域:

神经学神经学
患者报告的结果
临床评估临床评估

背景情况:

疲劳和疲劳是脊柱肌肉缩 (SMA) 的重要问题.
感知身体疲劳 (PPF) 对于理解SMA病理生理学至关重要,但缺乏具体的评估工具.
现有的基于绩效的指标突出了疲劳性,但由于规模不足,PPF仍未得到充分探索.

研究的目的:

开发和验证SMA EFFORT,这是一个新的患者报告的结果衡量标准,用于评估SMA患者的PPF.
建立一个标准化的方法来评估整个SMA频谱的PPF.
提供一个工具,以更好地了解SMA对身体健康的影响.

主要方法:

专家创建了一个全面的体育活动项目银行,按强度和持续时间分类.
使用SMA EFFORT尺度从所有SMA类型的个体收集国际数据.
开发一个复合评分系统 (PPF%) 以在人口和临床变量之间比较PPF.

主要成果:

在SMA EFFORT中,共有118名参与者完成了这项工作.
在非坐着者和坐着者之间,以及在有和没有呼吸辅助器的人之间,观察到PPF%得分的显著差异.
在接受疾病修饰疗法 (DMT) 治疗的参与者和未接受治疗的参与者之间,或基于脊柱结石手术史,没有发现PPF%得分的显著差异.

结论:

通过将活动与强度和持续时间联系起来,SMA EFFORT规模提供了一种标准化的PPF评级方法.
从规模的初始数据的洞察力将指导未来的代和调查.
"SMA EFFORT"旨在加强对SMA患者身体健康治疗效应的评估.

关键词:

神经肌肉疾病神经肌肉疾病患者报告的结果衡量措施.身体疲劳,身体疲劳.脊柱肌肉缩脊柱肌肉缩脊柱肌肉缩

相关概念视频

01:24

Muscle Recovery and Fatigue

1.9K

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...

1.9K

01:15

Myasthenia Gravis: Diagnostic Tests

601

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

601

01:28

Disorders of the Skeletal Muscle

857

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

857

01:26

Cross-bridge Cycle

116.6K

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.

116.6K

01:20

Myasthenia Gravis: Overview and Treatment

1.1K

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...